Roche
4300 Hacienda Drive
Pleasanton
California
94588
United States
Tel: 925-730-8000
Fax: 925-225-0479
Website: http://molecular.roche.com/
About Roche
Roche Molecular Solutions, one of the global business areas within Roche Diagnostics, brings together the diagnostic power of molecular, tissue and sequencing technologies.
With the goal of revolutionizing diagnostic decisions through integrated solutions, Roche Molecular Solutions brings together the latest technologies withinmolecular diagnostics (polymerase chain reaction or PCR-based testing), tissue diagnostics (tissue biopsy testing) and sequencing solutions (next-generation DNA and RNA sequence-based testing) to advance the standard of care for everyone.
Roche is the world leader in molecular and tissue diagnostics, and one of the leaders in clinical sequencing. As the innovation engine for Roche Diagnostics,Roche Molecular Solutions is translating cutting-edge science and innovation into clinical practice.
Visit our Career Blogs to see what our employees have to say about their life at Roche!
https://molecular.roche.com/
https://sequencing.roche.com
http://www.ventana.com/
101 articles about Roche
-
Roche Molecular Systems, Inc. Wins FDA Approval For First Ever Pap Alternative To Detect Cervical Cancer
4/25/2014
-
AdvanDx, Inc. Elects Former Roche Molecular Systems, Inc. CEO, Heiner Dreismann, Ph.D., to Its Board of Directors
3/27/2013
-
ATHENA Data Presented at International Papillomavirus Conference Support Use of Roche Molecular Systems’s cobas HPV Test in Primary Screening for Cervical Cancer
9/19/2011
-
Roche Molecular Systems, Inc. Release: Companion Diagnostic Test That Identifies Patients With Melanoma Tumor Mutation Available in Europe
8/23/2011
-
Roche's KRAS Diagnostic Test That Assists With Personalized Treatment of Colorectal Cancer Receives CE Mark
7/22/2011
-
Roche Molecular Systems, Inc. Release: Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Mark
5/23/2011
-
Roche Release: First Duplex Test for Parvovirus B19 and Hepatitis A Virus Now Available in the US
2/4/2011
-
Roche Molecular Systems, Inc. Launches Redesigned Website
1/18/2011
-
Roche Molecular Systems, Inc. and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer
10/11/2010
-
Myriad Genetics, Inc. Elects Former Roche Molecular Systems, Inc. CEO Heiner Dreismann to Its Board of Directors
6/11/2010
-
Preliminary Data from Roche Molecular Systems, Inc. ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping
2/18/2010
-
Roche Molecular Systems, Inc. Collaborates with Merck Sharp & Dohme on Developmental Test for Cancer-Related Gene Mutation Investigational AmpliChip p53 Test Designed to Screen for Genetic Mutation Tied to Therapeutic Resistance in Cancer Patients
2/17/2010
-
Roche Molecular Systems, Inc. Research Team Uses 454 Life Sciences Sequencing System for High-Resolution HLA Genotyping
10/27/2009
-
DeviceSpace Launches the 2009 U.S. Device™ Hotbed Campaign
6/30/2009
-
Dr. Heiner Dreismann, Former CEO of Roche Molecular Systems, Inc. and Diagnostics Veteran, Joins Shrink Nanotechnologies Board of Directors
6/25/2009
-
Enigma Diagnostics Announces a Signed Term Sheet for Patent Licenses with Roche Molecular Systems, Inc.
12/16/2008
-
Arcxis Biotechnologies and Roche Molecular Systems, Inc. Initiate Research Collaboration to Apply New Technology for Diagnostic Sample Preparation
9/23/2008
-
Asuragen, Inc. Licenses Roche Molecular Systems, Inc.'s Real-time Quantitative PCR Technology for Clinical Gene Expression Profiling
10/8/2007
-
Iconix Biosciences Adds Former President And CEO Of Roche Molecular Systems, Inc. To Its Board Of Directors
10/18/2006
-
Applied Biosystems, Roche Molecular Systems, Inc., Roche Molecular Systems, Inc., And MJ Research, Inc. (South San Francisco, CA) Reach Settlement Agreement Regarding Core And Real-Time Thermal Cyclers
2/13/2006